Hear from our Chief Scientific Officer, Amanda Tulk, about recent case studies by Dr. Gerald Fogarty. Dr. Fogarty used superficial radiotherapy to treat lesions of the ear, lips and eyelids.
XBeam V2: FDA-Approved Treatment Planning Software
The Fastest, Safest Way to Plan Superficial & Orthovoltage Treatment XBeam V2 is the revolutionary, FDA 510(k)-cleared dose planning software designed to automate planning, eliminate risk, and seamlessly integrates with the Concerto system, Xstrahl’s clinical...
